Evolus
EOLS
#7666
Rank
C$0.61 B
Marketcap
C$9.35
Share price
-6.86%
Change (1 day)
-3.21%
Change (1 year)

Earnings for Evolus (EOLS)

Earnings in 2026 (TTM): -C$42.85 Million

According to Evolus 's latest financial reports the company's current earnings are C$0.32 Billion. In 2025 the company made an earning of -C$73.08 Million a decrease over its 2024 earnings that were of -C$71.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Evolus from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$42.85 Million-41.37%
2025 -C$73.08 Million2.43%
2024 -C$71.35 Million-19.11%
2023 -C$88.2 Million-17.23%
2022 -C$0.11 Billion59.02%
2021 -C$67.02 Million-71.32%
2020 -C$0.24 Billion55.09%
2019 -C$0.16 Billion124.48%
2018 -C$67.11 Million298.96%
2017 -C$16.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion 414.62%๐Ÿ‡บ๐Ÿ‡ธ USA